GlassScriptPhysician profile
Merandian Mccoy
NPI 1477921013
$459.88
in general payments reported to CMS, 2019-2025
10 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.97 · 2024: $259 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $143.56 | 2024 | Intracept |
| Amgen INC. | $57.35 | 2024-2025 | Evenity, Prolia |
| Orthofix Medical, INC. | $55.68 | 2023-2024 | Cervical-Stim, Spinal-Stim, Spinal-Stim |
| Pacira Pharmaceuticals Incorporated | $50.66 | 2025 | Iovera, Zilretta, Exparel |
| Vertex Pharmaceuticals Incorporated | $40.07 | 2025 | |
| Radius Health, INC. | $37.78 | 2024-2025 | Tymlos |
| Davol INC. | $23.11 | 2025 | Arista |
| Cdc Medical LLC | $22.54 | 2024 | |
| Curonix LLC | $15.77 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Heron Therapeutics, INC. | $13.36 | 2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merandian Mccoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.